SETD2 and prostate adenocarcinoma: Other significantly detected prognostic alterations in genes were found in SETD2 in PRAD with an AUROC of 0.895 (Yuan et al., 2020) and NOTCH2 in CRC and STAD (Chu et al., 2011) with an high AUROC of 0.934, 0.919 (Figures 4G–I).